BioSpace News Archive

Pharm Country

New Study Finds Plasmapore®XP Surface Enhancement Demonstrates Enhanced Osseointegrative Properties

Aesculap Implant Systems, LLC today announced the publication of “Porous titanium-coated polyetheretherketone implants exhibit an improved bone–implant interface: an in vitro and in vivo biochemical, biomechanical, and histological study” in Medical Devices: Evidence and Research

January 28, 2019
·
4 min read
Policy

Pennsylvania Mesothelioma Victims Center Now Urges a Steel Mill Worker or Veteran with Mesothelioma in Pennsylvania to Call Them for Direct Access to Attorney Erik Karst for a Conversation About Compensation

According to the Pennsylvania Mesothelioma Victims Center, “We want a current or former steel mill worker, a US Navy Veteran, or a person with recently diagnosed mesothelioma or asbestos exposure lung cancer anywhere in Pennsylvania to call us anytime at 800-714-0303 for direct access to Erik Karst, f

January 28, 2019
·
3 min read
Drug Development

Dicerna Announces Dosing of First Volunteer in Phase 1 Clinical Trial of DCR-HBVS Designed for the Treatment of Chronic Hepatitis B Virus

Clinical Proof-of-Concept Data Expected in Second Half of 2019

January 28, 2019
·
7 min read
Berlinger Confirms Continued Production of Its Anti-doping Products

“ADO remains in Berlinger portfolio”

January 28, 2019
·
3 min read
BioMidwest

Study Show Chicago’s Older Voters Considering Leaving City; Concerned About Affordability, Crime, Education

Release of Survey Highlighting Voters’ Top Concerns Prior To Mayoral Election

January 28, 2019
·
3 min read
Genetown

Velphoro® Doubles Percentage of Patients Reaching Target Serum Phosphorous Levels in New Study Published in Journal of Renal Nutrition

Fresenius Medical Care North America Examines Impact of Sucroferric Oxydroxide on Hemodialysis Patients with Kidney Failure; High Serum Phosphorous Levels Previously Linked to Increased Cardiovascular Disease

January 28, 2019
·
4 min read
Business

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO

Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF), today announced that Robert Jacks has been appointed President & CEO.

January 28, 2019
·
4 min read
BioMidwest

Medical Cannabis Experts Launch Licensing Boot Camp for Minority- and Women-Owned Business Owners; Kickoff Events February 16 and 17 to Answer Questions for Cannabis Entrepreneurs in Missouri

Oaksterdam University, Green Rush Consulting, and Minorities for Medical Marijuana (M4MM) are partnering to launch the Cannabis Business Licensing Boot Camp (CBLB) program created specifically to help minority- and women-owned businesses prepare to obtain a cannabis business license in Missouri, which overwhelmingly passed Amendment 2 to make medical cannabis legal in the state.

January 28, 2019
·
4 min read
Business

MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostics

MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer critical clinical questions within the lung cancer continuum of care.

January 28, 2019
·
3 min read
Pharm Country

Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference

Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that an overview of the Company’s proprietary Lm platform and new information regarding the Company’s neoantigen-directed therapy programs, ADXS-NEO (customized, personalized neoantigens) and ADXS-HOT

January 28, 2019
·
2 min read